Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Goldberg

Showing results (71-80 of 92) with videos related to

Pageof 10
Sort By:
International Journal of Clinical Pharmacology and Therapeutics|October 30, 2001
Pharmacokinetics of rizatriptan in healthy elderly subjectsD G Musson, K L Birk, D L Panebianco, et al.
Clinical Pharmacology and Therapeutics|March 1, 1996
Phenobarbital minimally alters plasma concentrations of losartan and its active metabolite E-3174M R Goldberg, M W Lo, P J Deutsch, et al.
Allergy|November 12, 2017
NUT Co Reactivity - ACquiring Knowledge for Elimination Recommendations (NUT CRACKER) studyA Elizur, M Y Appel, L Nachshon, et al.
Journal of Clinical Pharmacology|October 1, 1995
Losartan does not affect the pharmacokinetics and pharmacodynamics of warfarinA N Kong, L Tomasko, S A Waldman, et al.
Clinical Pharmacology and Therapeutics|November 1, 1986
Reduction of liver plasma flow by caffeine and theophyllineJ Onrot, O Shaheen, I Biaggioni, et al.
Journal of Medicinal Chemistry|February 2, 1996
Nonpeptide angiotensin II receptor antagonists: the next generation in antihypertensive therapyR R Wexler, W J Greenlee, J D Irvin, et al.
Journal of Clinical Pharmacology|December 1, 1995
Absence of a pharmacokinetic interaction between losartan and hydrochlorothiazideJ B McCrea, M W Lo, L Tomasko, et al.
Surgery, Gynecology & Obstetrics|June 1, 1986
Abdominal aortic aneurysm resection in patients more than 80 years oldK A Harris, F M Ameli, M Lally, et al.
Journal of Clinical Pharmacology|September 21, 2001
Lack of pharmacokinetic and pharmacodynamic interaction between rizatriptan and paroxetineM R Goldberg, R C Lowry, D G Musson, et al.
Hypertension (Dallas, Tex. : 1979)|May 1, 1993
Effects of losartan on blood pressure, plasma renin activity, and angiotensin II in volunteersM R Goldberg, W Tanaka, A Barchowsky, et al.
Pageof 10

Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
International Journal of Clinical Pharmacology and Therapeutics|October 30, 2001
Pharmacokinetics of rizatriptan in healthy elderly subjectsD G Musson, K L Birk, D L Panebianco, et al.
Clinical Pharmacology and Therapeutics|March 1, 1996
Phenobarbital minimally alters plasma concentrations of losartan and its active metabolite E-3174M R Goldberg, M W Lo, P J Deutsch, et al.
Allergy|November 12, 2017
NUT Co Reactivity - ACquiring Knowledge for Elimination Recommendations (NUT CRACKER) studyA Elizur, M Y Appel, L Nachshon, et al.
Journal of Clinical Pharmacology|October 1, 1995
Losartan does not affect the pharmacokinetics and pharmacodynamics of warfarinA N Kong, L Tomasko, S A Waldman, et al.
Clinical Pharmacology and Therapeutics|November 1, 1986
Reduction of liver plasma flow by caffeine and theophyllineJ Onrot, O Shaheen, I Biaggioni, et al.
Journal of Medicinal Chemistry|February 2, 1996
Nonpeptide angiotensin II receptor antagonists: the next generation in antihypertensive therapyR R Wexler, W J Greenlee, J D Irvin, et al.
Journal of Clinical Pharmacology|December 1, 1995
Absence of a pharmacokinetic interaction between losartan and hydrochlorothiazideJ B McCrea, M W Lo, L Tomasko, et al.
Surgery, Gynecology & Obstetrics|June 1, 1986
Abdominal aortic aneurysm resection in patients more than 80 years oldK A Harris, F M Ameli, M Lally, et al.
Journal of Clinical Pharmacology|September 21, 2001
Lack of pharmacokinetic and pharmacodynamic interaction between rizatriptan and paroxetineM R Goldberg, R C Lowry, D G Musson, et al.
Hypertension (Dallas, Tex. : 1979)|May 1, 1993
Effects of losartan on blood pressure, plasma renin activity, and angiotensin II in volunteersM R Goldberg, W Tanaka, A Barchowsky, et al.
Pageof 10